E-viri
PDF
Recenzirano
Odprti dostop
-
Angelillo-Scherrer, Anne; Mansouri Taleghani, Behrouz; Förger, Frauke; Baerlocher, Gabriela M.; Pabst, Thomas; Pöllinger, Alexander; Banz, Yara; Geiser, Thomas; Kremer Hovinga, Johanna A.; Rovó, Alicia
Blood advances, 09/2019, Letnik: 3, Številka: 17Journal Article
•Reduction of APL antibodies by immunoadsorption may be a lifesaving therapy for the management of DAH with high titer of APL antibodies.•Autologous HSCT may be a valid treatment option in patients with primary APS and no response to standard immunosuppressive therapy.
